Impact of the COVID-19 pandemic on results and financial position
First written in FY2020-Q1. 12 of 15 entries say "Restated". Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company has reaffirmed that there have been no significant changes in the occurrence of major risks or in the matters concerning "Business and Other Risks" described in the previous fiscal year. - FY2024-H1RestatedAnnual report
「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company has reaffirmed that there have been no significant changes in the occurrence of major risks or in the matters concerning "Business and Other Risks" described in the previous fiscal year. - FY2023-Q3RestatedAnnual report
「Regarding the impact of COVID-19, there have been no significant changes from the assumptions described in section 2, "Basis for Preparation," (4) "Significant Accounting Estimates and Judgments Involving Estimates" of the securities report for the previous consolidated fiscal year.」
The Company has reaffirmed its previous risk assessment, stating that there had been no significant changes from the previous fiscal year in the assumptions underlying accounting estimates concerning the impact of COVID-19. - FY2023-Q2RestatedAnnual report
「Regarding the impact of COVID-19, there have been no significant changes from the assumptions described in section 2, "Basis for Preparation," (4) "Significant Accounting Estimates and Judgments Involving Estimates" of the securities report for the previous consolidated fiscal year.」
The Company has reaffirmed its previous risk assessment, stating that there had been no significant changes from the previous fiscal year in the assumptions underlying accounting estimates concerning the impact of COVID-19. - FY2023-Q1RestatedAnnual report
「Regarding the impact of COVID-19, there have been no significant changes from the assumptions described in section 2, "Basis for Preparation," (4) "Significant Accounting Estimates and Judgments Involving Estimates" of the securities report for the previous consolidated fiscal year.」
The Company has reaffirmed its previous risk assessment, stating that there had been no significant changes from the previous fiscal year in the assumptions underlying accounting estimates concerning the impact of COVID-19. - FY2022RestatedAnnual report
「Regarding the impact of the spread of COVID-19, as the timing of containment remains unforeseeable, the Company is making accounting estimates concerning impairment of non-financial assets and other matters based on the assumption that the impact will continue for a certain period beyond the following consolidated fiscal year.」
The Company continues to apply the accounting assumption that the impact of COVID-19 will continue for a certain period beyond the following consolidated fiscal year. - FY2022-Q3RestatedAnnual report
「Regarding the impact of the spread of COVID-19, there have been no significant changes from the assumptions described in section 2, "Basis for Preparation," (4) "Significant Accounting Estimates and Judgments Involving Estimates" of the securities report for the previous consolidated fiscal year.」
The Company continues to maintain its previous risk assessment, stating that there had been no significant changes from the previous fiscal year in the impact of the spread of COVID-19 on accounting estimates. - FY2022-Q2RestatedAnnual report
「Regarding the impact of the spread of COVID-19, there have been no significant changes from the assumptions described in section 2, "Basis for Preparation," (4) "Significant Accounting Estimates and Judgments Involving Estimates" of the securities report for the previous consolidated fiscal year.」
The Company continues to maintain its previous risk assessment, stating that there had been no significant changes from the previous fiscal year in the impact of the spread of COVID-19 on accounting estimates. - FY2022-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no significant changes in the occurrence of major risks that management recognizes as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, or in the matters concerning "Business and Other Risks" described in the securities report for the previous fiscal year, among the matters concerning the business and accounting conditions described in this quarterly report.」
The Company stated that there had been no significant changes in the major risks and that it continued to maintain its previous risk assessment regarding the impact of the spread of COVID-19. - FY2021-Q3RestatedAnnual report
「During the third quarter of the current consolidated cumulative period, there were no significant changes in the occurrence of major risks that management recognizes as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, or in the matters concerning "Business and Other Risks" described in the securities report for the previous fiscal year, among the matters concerning the business and accounting conditions described in this quarterly report. However, depending on the future course of the spread of COVID-19 and the timing of its containment, the operating results and financial position of the Group may be affected, and the Group will continue to closely monitor the situation.」
While stating that there had been no significant changes in the major risks, the Company continues to monitor the impact of the spread of COVID-19, the timing of its containment and other factors on operating results and financial position. - FY2021-Q2RestatedAnnual report
「During the second quarter of the current consolidated cumulative period, there were no significant changes in the occurrence of major risks that management recognizes as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, or in the matters concerning "Business and Other Risks" described in the securities report for the previous fiscal year, among the matters concerning the business and accounting conditions described in this quarterly report. However, depending on the future course of the spread of COVID-19 and the timing of its containment, the operating results and financial position of the Group may be affected, and the Group will continue to closely monitor the situation.」
While stating that there had been no significant changes in the major risks, the Company continues to monitor the impact of the spread of COVID-19, the timing of its containment and other factors on operating results and financial position. - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no significant changes in the occurrence of major risks that management recognizes as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, or in the matters concerning "Business and Other Risks" described in the securities report for the previous fiscal year, among the matters concerning the business and accounting conditions described in this quarterly report. However, as the spread of COVID-19 may affect the operating results and financial position of the Group, the Group will continue to closely monitor the situation.」
While stating that there had been no significant changes in the major risks, the Company said it would continue to closely monitor the impact of the spread of COVID-19 on operating results and financial position. - FY2020-Q3WorsenedAnnual report
「Regarding the impact of the spread of COVID-19, as of the end of the second quarter consolidated accounting period, the Company had assumed that the impact would continue through the end of the current consolidated fiscal year. However, as the timing of containment remains unforeseeable, the Company has changed this assumption to one that the impact will continue for a certain period beyond the following consolidated fiscal year and is making accounting estimates concerning impairment of non-financial assets and other matters.」
As the timing of containment of COVID-19 cannot be predicted, the assumption has been changed to one that its impact will continue for a certain period beyond the following consolidated fiscal year. - FY2020-Q2MaterialisedAnnual report
「Depending on the future course of the spread of the novel coronavirus, including when it subsides, the Group's business results and financial position may be affected, so we will continue to monitor developments.」
COVID-19 has already affected mobility, elective surgery, business media and commercial printing, among other areas, and the potential impact on future business results and financial position depending on when it subsides remains a risk. - FY2020-Q1First statedAnnual report
「As the spread of the novel coronavirus may affect the Group's business results and financial position, we will continue to closely monitor developments.」
The impact of the spread of the novel coronavirus on business results and financial position was identified as a risk for the first time. Some impact had already occurred during the quarter, including the temporary suspension of production at facilities in China and their reopening by the end of March, as well as lower demand for business media in Medical Technologies.